Scarica l'app Stockscreener
14.72
2.00%
-0.30
Dopo l'orario di chiusura:
14.75
0.03
+0.20%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Assembly Biosciences Inc Borsa (ASMB) Ultime notizie
(ASMB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
ARMISTICE CAPITAL, LLC Adjusts Stake in Assembly Biosciences Inc - GuruFocus.com
HC Wainwright Has Optimistic Outlook of ASMB FY2024 Earnings - MarketBeat
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Down 51.2% in October - MarketBeat
Analysts Just Slashed Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Numbers - Simply Wall St
Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates - Yahoo Finance
Analyzing Taysha Gene Therapies (NASDAQ:TSHA) & Gilead Sciences (NASDAQ:GILD) - Defense World
Assembly Biosciences: Q3 Earnings Snapshot - CTPost
Assembly Biosciences initiates at-the-market equity program - Investing.com India
Assembly Biosciences Inc (ASMB) Reports Q3 2024 Revenue of $6.8M, GAAP EPS Loss of $1.51, Misses Estimates - GuruFocus.com
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates - The Manila Times
Marquis Who's Who Honors Jonathan Colon, PhD, for Expertise in Biotechnology - 24-7 Press Release
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
When (ASMB) Moves Investors should Listen - Stock Traders Daily
Baker Lab’s AI-Driven Antibody Cage Technology Unlocked as Archon Biosciences - Genetic Engineering & Biotechnology News
Short Interest in Assembly Biosciences, Inc. (NASDAQ:ASMB) Declines By 7.9% - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
(ASMB) Investment Analysis and Advice - Stock Traders Daily
Microbiome Manufacturing Market Poised for Robust Growth at 15.4% CAGR by 2031 - WhaTech
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Update - MarketBeat
Assembly Biosciences, Inc.'s (NASDAQ:ASMB) market cap surged US$16m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St
Assembly Biosciences sees major stock purchase by investor Alexander Schornstein By Investing.com - Investing.com Canada
Alexander Schornstein Purchases 10,000 Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) Stock - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences CEO sells shares worth $2,917 to cover taxes By Investing.com - Investing.com South Africa
Assembly Biosciences CEO sells shares worth $2,917 to cover taxes - Investing.com India
How To Trade (ASMB) - Stock Traders Daily
Assembly Biosciences executive sells shares worth $2,325 By Investing.com - Investing.com South Africa
Assembly Biosciences executive sells shares worth $2,325 - Investing.com India
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Significant Growth in Short Interest - MarketBeat
Armistice Capital LLC Makes New Investment in Assembly Biosciences, Inc. (NASDAQ:ASMB) - MarketBeat
Investment Analysts’ Updated EPS Estimates for September 24th (AB, AG, AIOT, AIR, AMWL, ASMB, BAG, BDTX, BHVN, BIIB) - Defense World
Assembly Biosciences (NASDAQ:ASMB) Rating Reiterated by HC Wainwright - MarketBeat
(ASMB) Trading Signals - Stock Traders Daily
Assembly Biosciences advances genital herpes treatment study - Investing.com
Assembly Biosciences' Investigational Herpes Treatment Shows Antiviral Efficacy, Safety In Healthy Participants - AOL
Tonight | The Assembly on ABC and ABC iview S1E6 - TV Central
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting - EIN News
Assembly Biosciences' Investigational Herpes Treatment Shows Safety In Healthy Participants (UPDATED) - Yahoo Finance
The Assembly: Sept 24 - TV Tonight
Jefferies sees upside in Assembly Biosciences stock ahead of key Phase IA data - Investing.com
Schlumberger Limited (NYSE:SLB) Holdings Lifted by Richardson Financial Services Inc. - Defense World
Assembly Biosciences (NASDAQ:ASMB) Upgraded to Buy by Jefferies Financial Group - MarketBeat
Assembly Coffee closing after two years in Ballard - My Ballard
0.93%
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):